Xeltis is a European medical device company dedicated to developing care in heart valve replacement and vascular surgery. Its restorative heart valves enable the patient’s own body to naturally form a new heart valve through a therapeutic approach called Endogenous Tissue Restoration.
|Employees (est.) (Feb 2019)||51||(-5%)|
Xeltis total Funding
Xeltis latest funding size
Time since last funding
|a year ago|
|Life Sciences Partners, Kurma Partners, VI Partners, Ysios Capital|
Xeltis has 557 Twitter Followers. The number of followers has decreased 0.1% month over month and decreased 0.1% quarter over quarter
Who are Xeltis key executives?
Xeltis's key executives are Laurent Grandidier, Martin de Groot and Boris Warnack.
How many employees does Xeltis have?
Xeltis has 51 employees.
Who are Xeltis competitors?
Competitors of Xeltis include VertiFlex, REVA Medical and Arthrex.
Where is Xeltis headquarters?
Xeltis headquarters is located at 35 Seefeldstrasse, Zürich.
Where are Xeltis offices?
Xeltis has offices in Zürich and Eindhoven.
How many offices does Xeltis have?
Xeltis has 2 offices.